Ensign Peak Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $510K | Sell |
|
|||||
|
2025
Q2 | $899K | Sell |
|
|||||
|
2025
Q1 | $1M | Hold |
|
|||||
|
2024
Q4 | $1.11M | Hold |
|
|||||
|
2024
Q3 | $930K | Hold |
|
|||||
|
2024
Q2 | $982K | Hold |
|
|||||
|
2024
Q1 | $1.12M | Sell |
|
|||||
|
2023
Q4 | $1.99M | Hold |
|
|||||
|
2023
Q3 | $1.32M | Hold |
|
|||||
|
2023
Q2 | $1.52M | Hold |
|
|||||
|
2023
Q1 | $1.2M | Hold |
|
|||||
|
2022
Q4 | $1.01M | Buy |
|
|||||
|
2022
Q3 | $654K | Sell |
|
|||||
|
2022
Q2 | $1.99M | Buy |
|
|||||
|
2022
Q1 | $969K | Buy |
|
|||||
|
2021
Q4 | $695K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.54M | Sell |
|
|||||
|
2020
Q4 | $6.46M | Sell |
|
|||||
|
2020
Q3 | $5.21M | Buy |
|
|||||
|
2020
Q2 | $813K | Buy |
|
|||||
|
2020
Q1 | $604K | Buy |
|